214 related articles for article (PubMed ID: 23929213)
1. Circulating adiponectin levels and the risk of breast cancer: a meta-analysis.
Ye J; Jia J; Dong S; Zhang C; Yu S; Li L; Mao C; Wang D; Chen J; Yuan G
Eur J Cancer Prev; 2014 May; 23(3):158-65. PubMed ID: 23929213
[TBL] [Abstract][Full Text] [Related]
2. Circulating adiponectin and breast cancer risk: a systematic review and meta-analysis.
Macis D; Guerrieri-Gonzaga A; Gandini S
Int J Epidemiol; 2014 Aug; 43(4):1226-36. PubMed ID: 24737805
[TBL] [Abstract][Full Text] [Related]
3. Serum adiponectin in breast cancer: A meta-analysis.
Gu L; Cao C; Fu J; Li Q; Li DH; Chen MY
Medicine (Baltimore); 2018 Jul; 97(29):e11433. PubMed ID: 30024516
[TBL] [Abstract][Full Text] [Related]
4. Association of serum adiponectin with breast cancer: A meta-analysis of 27 case-control studies.
Yu Z; Tang S; Ma H; Duan H; Zeng Y
Medicine (Baltimore); 2019 Feb; 98(6):e14359. PubMed ID: 30732167
[TBL] [Abstract][Full Text] [Related]
5. Circulating adiponectin levels in various malignancies: an updated meta-analysis of 107 studies.
Wei T; Ye P; Peng X; Wu LL; Yu GY
Oncotarget; 2016 Jul; 7(30):48671-48691. PubMed ID: 27119501
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis: circulating adiponectin levels and risk of colorectal cancer and adenoma.
Xu XT; Xu Q; Tong JL; Zhu MM; Huang ML; Ran ZH; Xiao SD
J Dig Dis; 2011 Aug; 12(4):234-44. PubMed ID: 21791018
[TBL] [Abstract][Full Text] [Related]
7. Relation of serum adiponectin levels and obesity with breast cancer: a Japanese case-control study.
Minatoya M; Kutomi G; Shima H; Asakura S; Otokozawa S; Ohnishi H; Akasaka H; Miura T; Mori M; Hirata K
Asian Pac J Cancer Prev; 2014; 15(19):8325-30. PubMed ID: 25339024
[TBL] [Abstract][Full Text] [Related]
8. The role of circulating adiponectin in prostate cancer: a meta-analysis.
Liao Q; Long C; Deng Z; Bi X; Hu J
Int J Biol Markers; 2015 Feb; 30(1):e22-31. PubMed ID: 25450645
[TBL] [Abstract][Full Text] [Related]
9. Circulating adiponectin and risk of endometrial cancer.
Zheng Q; Wu H; Cao J
PLoS One; 2015; 10(6):e0129824. PubMed ID: 26030130
[TBL] [Abstract][Full Text] [Related]
10. Circulating adiponectin levels and risk of endometrial cancer: Systematic review and meta-analysis.
Li ZJ; Yang XL; Yao Y; Han WQ; Li BO
Exp Ther Med; 2016 Jun; 11(6):2305-2313. PubMed ID: 27284314
[TBL] [Abstract][Full Text] [Related]
11. Association of serum adiponectin levels with breast cancer risk.
Miyoshi Y; Funahashi T; Kihara S; Taguchi T; Tamaki Y; Matsuzawa Y; Noguchi S
Clin Cancer Res; 2003 Nov; 9(15):5699-704. PubMed ID: 14654554
[TBL] [Abstract][Full Text] [Related]
12. Prediagnostic leptin, adiponectin, C-reactive protein, and the risk of postmenopausal breast cancer.
Ollberding NJ; Kim Y; Shvetsov YB; Wilkens LR; Franke AA; Cooney RV; Maskarinec G; Hernandez BY; Henderson BE; Le Marchand L; Kolonel LN; Goodman MT
Cancer Prev Res (Phila); 2013 Mar; 6(3):188-95. PubMed ID: 23466816
[TBL] [Abstract][Full Text] [Related]
13. Circulating High-Molecular-Weight (HMW) Adiponectin Level Is Related with Breast Cancer Risk Better than Total Adiponectin: A Case-Control Study.
Guo MM; Duan XN; Cui SD; Tian FG; Cao XC; Geng CZ; Fan ZM; Wang X; Wang S; Jiang HC; Zhang JG; Jin F; Tang JH; Liang H; Yang ZL; Wang HB; Wang QT; Li GL; Li L; Zhu SG; Zuo WS; Liu LY; Wang L; Ma DD; Liu SC; Xiang YJ; Liu L; Ye CM; Zhou WZ; Wang F; Yu LX; Ma ZB; Yu ZG
PLoS One; 2015; 10(6):e0129246. PubMed ID: 26070203
[TBL] [Abstract][Full Text] [Related]
14. Roles of adiposity, lifetime physical activity and serum adiponectin in occurrence of breast cancer among Malaysian women in Klang Valley.
Shahar S; Salleh RM; Ghazali AR; Koon PB; Mohamud WN
Asian Pac J Cancer Prev; 2010; 11(1):61-6. PubMed ID: 20593932
[TBL] [Abstract][Full Text] [Related]
15. The role of adiponectin in breast cancer: a meta-analysis.
Liu LY; Wang M; Ma ZB; Yu LX; Zhang Q; Gao DZ; Wang F; Yu ZG
PLoS One; 2013; 8(8):e73183. PubMed ID: 23991180
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin and Endometrial Cancer: A Systematic Review and Meta-Analysis.
Zeng F; Shi J; Long Y; Tian H; Li X; Zhao AZ; Li RF; Chen T
Cell Physiol Biochem; 2015; 36(4):1670-8. PubMed ID: 26160484
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum visfatin/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters.
Dalamaga M; Karmaniolas K; Papadavid E; Pelekanos N; Sotiropoulos G; Lekka A
Menopause; 2011 Nov; 18(11):1198-204. PubMed ID: 21712732
[TBL] [Abstract][Full Text] [Related]
18. Resistin, visfatin, adiponectin, and leptin: risk of breast cancer in pre- and postmenopausal saudi females and their possible diagnostic and predictive implications as novel biomarkers.
Assiri AM; Kamel HF; Hassanien MF
Dis Markers; 2015; 2015():253519. PubMed ID: 25838618
[TBL] [Abstract][Full Text] [Related]
19. Serum resistin is inversely related to breast cancer risk in premenopausal women.
Georgiou GP; Provatopoulou X; Kalogera E; Siasos G; Menenakos E; Zografos GC; Gounaris A
Breast; 2016 Oct; 29():163-9. PubMed ID: 27521488
[TBL] [Abstract][Full Text] [Related]
20. Circulating adiponectin, leptin and adiponectin-leptin ratio and endometrial cancer risk: Evidence from a meta-analysis of epidemiologic studies.
Gong TT; Wu QJ; Wang YL; Ma XX
Int J Cancer; 2015 Oct; 137(8):1967-78. PubMed ID: 25899043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
